Literature DB >> 33682877

Bipartite graph-based approach for clustering of cell lines by gene expression-drug response associations.

Calvin Chi1, Yuting Ye2, Bin Chen3,4, Haiyan Huang1,5.   

Abstract

MOTIVATION: In pharmacogenomic studies, the biological context of cell lines influences the predictive ability of drug-response models and the discovery of biomarkers. Thus, similar cell lines are often studied together based on prior knowledge of biological annotations. However, this selection approach is not scalable with the number of annotations, and the relationship between gene-drug association patterns and biological context may not be obvious.
RESULTS: We present a procedure to compare cell lines based on their gene-drug association patterns. Starting with a grouping of cell lines from biological annotation, we model gene-drug association patterns for each group as a bipartite graph between genes and drugs. This is accomplished by applying sparse canonical correlation analysis (SCCA) to extract the gene-drug associations, and using the canonical vectors to construct the edge weights. Then, we introduce a nuclear norm-based dissimilarity measure to compare the bipartite graphs. Accompanying our procedure is a permutation test to evaluate the significance of similarity of cell line groups in terms of gene-drug associations. In the pharmacogenomics datasets CTRP2, GDSC2, and CCLE, hierarchical clustering of carcinoma groups based on this dissimilarity measure uniquely reveals clustering patterns driven by carcinoma subtype rather than primary site. Next, we show that the top associated drugs or genes from SCCA can be used to characterize the clustering patterns of haematopoietic and lymphoid malignancies. Finally, we confirm by simulation that when drug responses are linearly-dependent on expression, our approach is the only one that can effectively infer the true hierarchy compared to existing approaches. AVAILABILITY: Bipartite graph-based hierarchical clustering is implemented in R and can be obtained from CRAN: https://CRAN.R-project.org/package=hierBipartite. The source code is available at https://github.com/CalvinTChi/hierBipartite. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) (2021). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 33682877      PMCID: PMC8428606          DOI: 10.1093/bioinformatics/btab143

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  38 in total

1.  ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.

Authors:  Qingfei Jiang; Leslie A Crews; Christian L Barrett; Hye-Jung Chun; Angela C Court; Jane M Isquith; Maria A Zipeto; Daniel J Goff; Mark Minden; Anil Sadarangani; Jessica M Rusert; Kim-Hien T Dao; Sheldon R Morris; Lawrence S B Goldstein; Marco A Marra; Kelly A Frazer; Catriona H M Jamieson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-28       Impact factor: 11.205

2.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

3.  Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis.

Authors:  Ronglai Shen; Adam B Olshen; Marc Ladanyi
Journal:  Bioinformatics       Date:  2009-09-16       Impact factor: 6.937

4.  DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines.

Authors:  Jordana T Bell; Athma A Pai; Joseph K Pickrell; Daniel J Gaffney; Roger Pique-Regi; Jacob F Degner; Yoav Gilad; Jonathan K Pritchard
Journal:  Genome Biol       Date:  2011-01-20       Impact factor: 13.583

5.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

6.  Context Sensitive Modeling of Cancer Drug Sensitivity.

Authors:  Bo-Juen Chen; Oren Litvin; Lyle Ungar; Dana Pe'er
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 7.  Machine learning approaches to drug response prediction: challenges and recent progress.

Authors:  George Adam; Ladislav Rampášek; Zhaleh Safikhani; Petr Smirnov; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  NPJ Precis Oncol       Date:  2020-06-15

8.  The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia.

Authors:  Sanne Noort; Priscilla Wander; Todd A Alonzo; Jenny Smith; Rhonda E Ries; Robert B Gerbing; M Emmy M Dolman; Franco Locatelli; Dirk Reinhardt; Andre Baruchel; Jan Stary; Jan J Molenaar; Ronald W Stam; Marry M van den Heuvel-Eibrink; Michel C Zwaan; Soheil Meshinchi
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

9.  RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.

Authors:  Ashakumary Lakshmikuttyamma; Naoto Takahashi; Elodie Pastural; Emina Torlakovic; Hesham M Amin; Guillermo Garcia-Manero; Michael Voralia; Magdalena Czader; John F DeCoteau; C Ronald Geyer
Journal:  J Hematol Oncol       Date:  2009-07-14       Impact factor: 17.388

10.  Correlating chemical sensitivity and basal gene expression reveals mechanism of action.

Authors:  Matthew G Rees; Brinton Seashore-Ludlow; Jaime H Cheah; Drew J Adams; Edmund V Price; Shubhroz Gill; Sarah Javaid; Matthew E Coletti; Victor L Jones; Nicole E Bodycombe; Christian K Soule; Benjamin Alexander; Ava Li; Philip Montgomery; Joanne D Kotz; C Suk-Yee Hon; Benito Munoz; Ted Liefeld; Vlado Dančík; Daniel A Haber; Clary B Clish; Joshua A Bittker; Michelle Palmer; Bridget K Wagner; Paul A Clemons; Alykhan F Shamji; Stuart L Schreiber
Journal:  Nat Chem Biol       Date:  2015-12-14       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.